Bixiye
P26R1-19 Update: New Medical, Medical Drug and Behavioral Health Policy Management Updates for Commercial & Medicare Advantage Lines of Business – Effective May 6, 2019
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 01, 2019
Dukumentiyadda & Foomamka Natiijooyinka
Soo bandhiga 2631 - 2640 ee natiijooyinka 3167
Bixiye
2019 April Bulletins
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 01, 2019
Bixiye
P36-19 Medical Oncology Drug Prior Authorization Updates for Fully Insured Commercial and Medicare Advantage Subscribers – eviCore Healthcare Utilization Management Program
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 01, 2019
Bixiye
P38-19 Change to Outpatient Therapies Prior Authorization Requirements for Medicare Advantage Subscribers
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 01, 2019
Bixiye
P33-19 New Medical, Medical Drug and Behavioral Health Policy Management Updates for Commercial & Medicare Advantage Lines of Business
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 01, 2019
Bixiye
P35-19 Appeals Policy for no Prior Authorization Effective June 3, 2019
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 01, 2019
Bixiye
QP30-19 Pharmacy Benefit Update – New Drug-Related Prior Authorization with Quantity Limit Criteria: Hereditary transthyretin-mediated (hATTR) Amyloidosis Neuropathy
Taariikhda uu dhaqangalayo Barnaamijka: Mar 27, 2019
Bixiye
QP33-19 SmartChoice Program for Fully Insured Commercial Products
Taariikhda uu dhaqangalayo Barnaamijka: Mar 27, 2019
Bixiye
QP31-19 Change to Outpatient Therapies Prior Authorization Requirements for Medicare Advantage Subscribers
Taariikhda uu dhaqangalayo Barnaamijka: Mar 27, 2019
Bixiye
QP29-19 Pharmacy Benefit Update – New Drug-Related Prior Authorization with Quantity Limit Criteria: Arikayce
Taariikhda uu dhaqangalayo Barnaamijka: Mar 27, 2019